Search research articles
Contact Us
Filters
Showing results (691-700 of 1,155) with videos related to
Page
of 116
Sort By:
Oncotarget
|
September 8, 2016
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia
Stefania Fiorcari, Rossana Maffei, Valentina Audrito, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 21, 2007
Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer
Stephen A Cannistra, Ursula A Matulonis, Richard T Penson, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 19, 2013
Protocol requirements and diagnostic value of PET/MR imaging for liver metastasis detection
Caecilia S Reiner, Paul Stolzmann, Lars Husmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2008
Maintenance treatment with bevacizumab prolongs survival in an in vivo ovarian cancer model
Seiji Mabuchi, Yoshito Terai, Kenichiro Morishige, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 12, 2018
Automated detection of lung cancer at ultralow dose PET/CT by deep neural networks - Initial results
Moritz Schwyzer, Daniela A Ferraro, Urs J Muehlematter, et al.
Preventive Medicine
|
March 8, 2021
Impact and cost-effectiveness of strategies to accelerate cervical cancer elimination: A model-based analysis
Allison Portnoy, Kine Pedersen, Lill Trogstad, et al.
Life (Basel, Switzerland)
|
September 28, 2021
When SUV Matters: FDG PET/CT at Baseline Correlates with Survival in Soft Tissue and Ewing Sarcoma
Ruben I Hack, Anton S Becker, Beata Bode-Lesniewska, et al.
The AAPS Journal
|
April 17, 2024
Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies
Helmut Schütz, Divan A Burger, Erik Cobo, et al.
Insights Into Imaging
|
April 15, 2022
Quantitative imaging parameters to predict the local staging of prostate cancer in intermediate- to high-risk patients
Riccardo Laudicella, Stephan Skawran, Daniela A Ferraro, et al.
Life (Basel, Switzerland)
|
September 23, 2022
Can Dynamic Whole-Body FDG PET Imaging Differentiate between Malignant and Inflammatory Lesions?
Stephan Skawran, Michael Messerli, Fotis Kotasidis, et al.
Page
of 116
Search research articles
Search
Showing results (691-700 of 1,155) with videos related to
Sort By:
Page
of 116
Oncotarget
|
September 8, 2016
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia
Stefania Fiorcari, Rossana Maffei, Valentina Audrito, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 21, 2007
Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer
Stephen A Cannistra, Ursula A Matulonis, Richard T Penson, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 19, 2013
Protocol requirements and diagnostic value of PET/MR imaging for liver metastasis detection
Caecilia S Reiner, Paul Stolzmann, Lars Husmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2008
Maintenance treatment with bevacizumab prolongs survival in an in vivo ovarian cancer model
Seiji Mabuchi, Yoshito Terai, Kenichiro Morishige, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 12, 2018
Automated detection of lung cancer at ultralow dose PET/CT by deep neural networks - Initial results
Moritz Schwyzer, Daniela A Ferraro, Urs J Muehlematter, et al.
Preventive Medicine
|
March 8, 2021
Impact and cost-effectiveness of strategies to accelerate cervical cancer elimination: A model-based analysis
Allison Portnoy, Kine Pedersen, Lill Trogstad, et al.
Life (Basel, Switzerland)
|
September 28, 2021
When SUV Matters: FDG PET/CT at Baseline Correlates with Survival in Soft Tissue and Ewing Sarcoma
Ruben I Hack, Anton S Becker, Beata Bode-Lesniewska, et al.
The AAPS Journal
|
April 17, 2024
Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies
Helmut Schütz, Divan A Burger, Erik Cobo, et al.
Insights Into Imaging
|
April 15, 2022
Quantitative imaging parameters to predict the local staging of prostate cancer in intermediate- to high-risk patients
Riccardo Laudicella, Stephan Skawran, Daniela A Ferraro, et al.
Life (Basel, Switzerland)
|
September 23, 2022
Can Dynamic Whole-Body FDG PET Imaging Differentiate between Malignant and Inflammatory Lesions?
Stephan Skawran, Michael Messerli, Fotis Kotasidis, et al.
Page
of 116